A multi-criteria decision-making framework for the selection of strategies for acquiring biopharmaceutical manufacturing capacity

Selecting an appropriate path for acquiring commercial-scale biopharmaceutical manufacturing capacity often requires the rationalisation of multiple conflicting criteria and the reconciling of financial and non-financial issues. Multi-criteria decision-making (MCDM) can provide a holistic framework for evaluating such scenarios. This paper presents the development of a decision-support framework for decision-making scenarios involving the acquisition of commercial-scale biopharmaceutical manufacturing capacity that utilises MCDM. To illustrate the functionality of the framework, a hypothetical scenario was constructed based on a biopharmaceutical company faced with a number of options for acquiring commercial manufacturing capacity. A deterministic analysis showed that building manufacturing capacity was the highest ranking option for the scenario considered. Stochastic analyses demonstrated that this option was also the highest ranking overall.

[1]  Jeffrey S. Stonebraker.  How Bayer Makes Decisions to Develop New Drugs , 2002, Interfaces.

[2]  S. Zahra,et al.  The effects of alliance portfolio characteristics and absorptive capacity on performance A study of biotechnology firms , 2001 .

[3]  S Karri,et al.  A Tool for Modeling Strategic Decisions in Cell Culture Manufacturing , 2000, Biotechnology progress.

[4]  Evangelos Triantaphyllou,et al.  Multi-criteria Decision Making Methods: A Comparative Study , 2000 .

[5]  I. Grossmann,et al.  Simultaneous Planning for New Product Development and Batch Manufacturing Facilities , 2001 .

[6]  K. Demeter.  Manufacturing strategy and competitiveness , 2003 .

[7]  Suzanne S. Farid,et al.  Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma , 2007, Comput. Chem. Eng..

[8]  Costas D. Maranas,et al.  Real-Options-Based Planning Strategies under Uncertainty , 2004 .

[9]  Arie Y. Lewin,et al.  Managing partnerships and strategic alliances: raising the odds of success , 2000 .

[10]  Suzanne S. Farid,et al.  Modelling of the biopharmaceutical drug development pathway and portfolio management , 2005, Comput. Chem. Eng..

[11]  I. Karimi,et al.  Regulatory Factors and Capacity-Expansion Planning in Global Chemical Supply Chains , 2004 .

[12]  Suzanne S Farid,et al.  Decision‐Support Tool for Assessing Biomanufacturing Strategies under Uncertainty: Stainless Steel versus Disposable Equipment for Clinical Trial Material Preparation , 2008, Biotechnology progress.

[13]  Steve Brown,et al.  Manufacturing strategy, manufacturing seniority and plant performance in quality , 1998 .

[14]  D. Probert,et al.  Make vs. buy decisions: a process incorporating multi-attribute decision-making , 2002 .

[15]  Marko Närhi,et al.  Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  Toshikazu Kimura,et al.  Monte Carlo analysis of convertible bonds with reset clauses , 2006, Eur. J. Oper. Res..

[17]  Min Ding,et al.  Valuation and Design of Pharmaceutical R&D Licensing Deals , 2005 .

[18]  Yuhong Zhou,et al.  Application of a Decision‐Support Tool to Assess Pooling Strategies in Perfusion Culture Processes under Uncertainty , 2008, Biotechnology progress.

[19]  A. Westerberg,et al.  Multiobjective decision processes under uncertainty : Applications, problem formulations, and solution strategies , 2005 .

[20]  Suzanne S Farid,et al.  A computer‐aided approach to compare the production economics of fed‐batch and perfusion culture under uncertainty , 2006, Biotechnology and bioengineering.

[21]  Lazaros G. Papageorgiou,et al.  A hierarchical solution approach for multi-site capacity planning under uncertainty in the pharmaceutical industry , 2004, Comput. Chem. Eng..

[22]  Yuhong Zhou,et al.  A Software Tool to Assist Business‐Process Decision‐Making in the Biopharmaceutical Industry , 2005, Biotechnology progress.

[23]  S. Bhatia,et al.  The Road Ahead for Biologics Manufacturing , 2002 .

[24]  Eswaran Subrahmanian,et al.  Design and planning under uncertainty: issues on problem formulation and solution , 2003, Comput. Chem. Eng..

[25]  Lazaros G. Papageorgiou,et al.  An Aggregation Approach for Capacity Planning under Uncertainty for the Pharmaceutical Industry , 2003 .

[26]  A. Volgenant,et al.  Solving some lexicographic multi-objective combinatorial problems , 2002, Eur. J. Oper. Res..

[27]  Suzanne S Farid,et al.  Combining Multiple Quantitative and Qualitative Goals When Assessing Biomanufacturing Strategies under Uncertainty , 2008, Biotechnology progress.

[28]  Tadeusz Sawik.  A lexicographic approach to bi-objective loading of a flexible assembly system , 1998, Eur. J. Oper. Res..

[29]  Ralph E. Steuer,et al.  Multiple criteria decision making combined with finance: A categorized bibliographic study , 2003, Eur. J. Oper. Res..

[30]  T. Mcgurk.  Ramping up and ensuring supply capability for biopharmaceuticals , 2004 .